Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
With
National Cancer Institute (NCI)
Age
21–90
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women who have received surgical treatment for breast cancer (Stage I-III), including mastectomy, lumpectomy, sentinel lymph node biopsy (SLNB), SLNB plus lymph node dissection or axillary lymph nodes dissection
Report any persistent or intermittent pain or lymphedema symptoms in the ipsilateral upper limb or body at least 8 weeks after surgery, that is, beyond the expected period of healing
May or may not have had neoadjuvant therapy or adjuvant therapy of chemotherapy or radiation
Have history or no history of lymphedema or have or not been treated for lymphedema;
Able to speak and understand English since the proposed usability testing is designed to only test the English version of the intervention.
Women willing to come to the NYU Perlmutter Cancer Center for the research visit.
You may not be if
Women diagnosed with breast cancer but did not undergo surgical treatment as breast surgery and removal of lymph nodes are the major treatment-related risk factors for lymphedema;
Known metastatic disease (Stage IV), recurrence of cancer, or lymphedema due to cancer recurrence, or other bulk disease in the thoracic or cervical regions;
Women with renal or heart failure, cardiac pacemaker or defibrillator, artificial limbs, or pregnant women as accurate measurement of body mass index (BMI) may not be possible with an impedance device according to the manufactures.
Clareo Health | Pilot Usability and Feasibility Testing on Kinect-Enhanced Training System for Lymphatic Exercises
